Business Context and Reporting Period
Company: The Joint Corp. (JYNT)
Filing Type: Form 8-K (Current Report)
Reporting Period: Events occurring between December 5, 2025, and December 11, 2025.
Business Overview: The registrant operates company-owned and managed chiropractic clinics and engages in franchise agreements.
Key Financial Metrics and Transaction Details
This filing reports on specific material agreements rather than periodic financial performance. No revenue, profit, cash flow, or margin data is provided in this document.
- Southeast Transaction (Item 1.01):
- Assets Sold: 22 clinics in Virginia, North Carolina, and South Carolina.
- Total Purchase Price: $1,482,800 (subject to adjustments).
- Payment Structure:
- $1,000,000 in cash.
- $667,800 in prorated franchise fees.
- $185,000 credit for clinic renovations.
- Down Payment: $100,000 paid upon execution.
- Balance Payment: Remaining balance payable via promissory notes at closing.
- Elite Chiro Group Transaction (Item 1.02):
- Proposed Assets: 45 clinics in Southern California.
- Proposed Price: $4.5 million (terminated).
- Financial Impact: No penalties incurred upon termination.
Material Changes and Transaction Status
Active Agreement: On December 5, 2025, the company entered into the "Southeast Purchase Agreement" to sell 22 clinics. The transaction is conditional upon the assignment of leases for at least 17 of the 22 clinics or the execution of specific management agreements.
Terminated Agreement: On December 11, 2025, the company terminated the "Elite Chiro Group Purchase Agreement" (dated November 2, 2025) regarding the sale of 45 Southern California clinics. Termination was due to the buyer's failure to meet closing conditions.
Outlook, Risks, and Contingencies
Closing Conditions: The Southeast Transaction is not guaranteed to close. It is expressly conditioned on lease assignments or the execution of management agreements for the clinics involved.
Risks: The filing highlights the risk of failed transactions, as evidenced by the termination of the Elite Chiro Group deal. The Southeast Transaction remains subject to customary closing conditions.
Management Commentary: The filing contains no forward-looking guidance or management commentary beyond the factual description of the agreements and their status.
Key Facts for Investor Verification
- Verify the status of lease assignments for the 17+ clinics required to close the Southeast Transaction.
- Confirm the execution of the promissory notes for the remaining balance of the Southeast Purchase Price.
- Assess the impact of the terminated $4.5 million Southern California deal on the company's strategic growth plans.
- Review the specific terms of the franchise agreements and management agreements referenced in the Southeast Purchase Agreement.